Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02779751
Title A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

Her2-receptor negative breast cancer

lung non-small cell carcinoma

Therapies

Abemaciclib + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | BEL


No variant requirements are available.